CHINA PHARMA HOLDINGS, INC. (CPHI) › Shareholders' EquityCHINA PHARMA HOLDINGS, INC. (CPHI) — Shareholders' EquityAnnual figures by period end, from SEC filings.2009-12-31: $87.87M2010-12-31: $117.94M2011-12-31: $142.48M2012-12-31: $148.52M2013-12-31: $132.94M2014-12-31: $92.74M2015-12-31: $72.64M2016-12-31: $58.91M2017-12-31: $43.07M2018-12-31: $30.20M2019-12-31: $9.24M2020-12-31: $8.00M2021-12-31: $6.02M2022-12-31: $4.29M2023-12-31: $7.45M2024-12-31: $7.75M2025-12-31: $22.74M$22.74M2009-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$22.74M+193.5%2026-04-01Balance as of period end2024-12-31$7.75M+3.9%2026-04-01Balance as of period end2023-12-31$7.45M+73.8%2026-04-01Balance as of period end2022-12-31$4.29M-28.7%2025-03-31Balance as of period end2021-12-31$6.02M-24.8%2024-04-01Balance as of period end2020-12-31$8.00M-13.3%2023-03-30Balance as of period end2019-12-31$9.24M-69.4%2022-03-30Balance as of period end2018-12-31$30.20M-29.9%2021-03-26Balance as of period end2017-12-31$43.07M-26.9%2020-03-30Balance as of period end2016-12-31$58.91M-18.9%2019-03-28Balance as of period end2015-12-31$72.64M-21.7%2018-04-02Balance as of period end2014-12-31$92.74M-30.2%2016-03-30Balance as of period end2013-12-31$132.94M-10.5%2015-12-28Balance as of period end2012-12-31$148.52M+4.2%2014-03-20Balance as of period end2011-12-31$142.48M+20.8%2013-03-14Balance as of period end2010-12-31$117.94M+34.2%2012-03-14Balance as of period end2009-12-31$87.87M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)